Genomic Valley Biotech Ltd

NSE: GVBL · BSE: 539206 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹32.24
Market cap: ₹9.85 Cr
Revenue (annual): ₹0.27 Cr
Net profit (annual): ₹0.03 Cr
P/E (TTM): 484.2×Sector 47.3×
Promoter holding: 46.06%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

31 Aug 2026 15:33 IST BSE

Other Announcement

Genomic Valley Biotech Other Announcement

Genomic Valley Biotech Limited received approval from the Registrar of Companies to extend the AGM deadline for FY26 to 31st December 2026. This is a regulatory compliance update.

Read the filing ↗

14 Aug 2026 16:00 IST BSE

Financial Results

Genomic Valley Biotech Q1 FY27 Results: Net Profit ₹146,162 Cr, Down 40.7% YoY

Genomic Valley Biotech Ltd reported revenue from operations of ₹380,000 Cr (-57.8% YoY) and net profit of ₹146,162 Cr (-40.7% YoY) for Q1 FY27.

Key figure: Net profit ₹146,162 Cr · -40.7% YoY

Open full results → Read the filing ↗

6 Aug 2026 12:56 IST BSE

Board Meeting Date

Genomic Valley Biotech Board Meeting Date

Genomic Valley Biotech Limited has scheduled a Board Meeting for August 14, 2026. The board will consider and approve unaudited standalone financial results for the June quarter.

Read the filing ↗